P. Robinson

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

N. Lewin-Koh, I. Rosas, N. Hanania, 2021, Intensive Care Medicine.

Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting.

M. Molimard, V. Le Gros, I. Bourdeix, 2010, Journal of aerosol medicine and pulmonary drug delivery.

Use of therapeutic drug monitoring in CML patients on imatinib

G. Marit, F. Mahon, M. Molimard, 2007 .

Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.

P. Pitel, C. Cunningham, P. Flynn, 1995, The Journal of pediatrics.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

J. P. Sy, H. Tiddens, J. Sy, 2001, The Journal of pediatrics.

Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma.

M. Humbert, A. Didier, P. Chanez, 2010, Respiratory medicine.

Therapeutic drug monitoring in CML patients on imatinib. Authors' reply

B. Druker, M. Deininger, M. Egorin, 2007 .